The NRG Oncology Podcast

NRG Oncology

Clinical Trials

Chemotherapy

Immunotherapy

National Cancer Institute

Radiation Oncology

NRG Oncology

Rtog-Gog 0724

Pancreatic Cancer

Cervical Cancer

Medical Oncology

Targeted Therapy

Thoracic Oncology

Lung Cancer

Medical Oncology Committee

Gynecologic Cancers

Radiation Therapy

RTOG 0848

Paclitaxel

Carboplatin

Theranostics

The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.

13 ratings

Publishes	Twice monthly	Episodes	40	Founded	2 years ago
Number of Listeners		Categories	Health & FitnessMedicine

Listen to this Podcast

Guests Hosts Reviews Charts Talking Points

Latest Episodes

NRG-BR009 and the Importance of Cancer Screening

Our co-hosts discuss the NRG-BR009 'OFSET' study for premenopausal ER-positive/HER2-negative breast cancer patients that have a high risk of cancer returning with study team members Dr. Shannon Puhalla and Dr. Sandra Swain. Also on this episode, we i... more

25 Mar 2026 • 51 min

Health Policy, Access, and Patient-Reported Outcomes

American Medical Association President, Dr. Bobby Mukkamala, discusses how his personal experiences in his cancer journey impact his outlook and goals in his AMA Presidency & Dr. James Yu discusses his experiences using patient-reported outcomes from... more

23 Feb 2026 • 37 min

YouTube

NRG-HN009 Reported at the MHNCS 2026 and NRG-HN010

Our co-hosts interview NRG-HN009 PI Dr. Paul Harari on the recently reported initial results of NRG-HN009 at the 2026 Multidisciplary Head and Neck Cancer Symposium. Additionally, this episode discusses NRG-HN010 for HER2-expressing salivary gland ca... more

20 Feb 2026 • 37 min

YouTube

NRG Protocol Operations Management Committee

Our co-hosts discuss who the NRG Protocol Operations Management "POM" Committee is and what they are responsible for with outgoing Chair, Dr. Maria Werner-Wasik and incoming Chair, Dr. Alexandra Thomas.

24 Jan 2026 • 22 min

YouTube

Key Facts

Accepts Guests

Accepts Sponsors

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASTRO JournalsVarious

White Coat Investor PodcastDr. Jim Dahle of the White Coat Investor

PTIESPN, Tony Kornheiser, Michael Wilbon

JAMA Clinical ReviewsJAMA Network

The DailyThe New York Times

Recent Guests

Bobby Mukkamala

2025-2026 AMA President; Otolaryngologist

American Medical Association

Episode: Health Policy, Access, and Patient-Reported Outcomes

James Yu

Professor of Radiation Oncology at Dartmouth; PROs expert

Dartmouth College / NH Dartmouth Cancer Center; editor-in-chief of JNCI Spectrum

Episode: Health Policy, Access, and Patient-Reported Outcomes

Paul Harari

Dr. Paul Harari, radiotherapy expert; presented the HN009 results

University of Wisconsin–Madison (former chair, Radiation Oncology)

Episode: NRG-HN009 Reported at the MHNCS 2026 and NRG-HN010

Alan Ho

Dr. Alan Ho, HS HER2-positive salivary gland cancers specialist; NRG HN010 PI

Memorial Sloan Kettering Cancer Center

Episode: NRG-HN009 Reported at the MHNCS 2026 and NRG-HN010

Dr. Maria Werner-Wasik

Outgoing chair of the Protocol Operations Management Committee

Thomas Jefferson University / Legacy RTOG

Episode: NRG Protocol Operations Management Committee

Dr. Alexandra Thomas

Incoming chair of the Protocol Operations Management Committee

Wake Forest / Duke University

Episode: NRG Protocol Operations Management Committee

Dian Wang

Professor of Radiation Oncology

Rush University Medical Center

Episode: Sarcoma in NRG and Through the CT3 Foundation with Special Guests

William Tseng

Surgical Oncologist specializing in sarcoma

City of Hope Cancer Center

Episode: Sarcoma in NRG and Through the CT3 Foundation with Special Guests

Chris Taylor

Major League Baseball player

Los Angeles Angels (formerly Seattle Mariners, Dodgers)

Episode: Sarcoma in NRG and Through the CT3 Foundation with Special Guests

Hosts

Dr. Stephen Chun

Co-host and expert in radiation oncology involved with NRG Oncology, frequently discussing clinical trials and treatment advancements.

Dr. Lauren Henke

Co-host and gynecologic oncologist, bringing insights on clinical trials and women's health issues related to oncology.

Reviews

5.0 out of 5 stars from 13 ratings

A must listen for anyone involved in the field of radiation medicine
Drs. Chun and Henke do a masterful job of guiding the listener through the key aspects of the discussion.
Apple Podcasts
5
Frustrated with Apple TV
United States5 months ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The hosts guide listeners through key discussions in oncology expertly. Many find it a must-listen resource for oncology professionals, highlighting the depth of conversations that address crucial issues in cancer care and research.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#36	India/Health & Fitness/Medicine
Apple Podcasts	#151	Philippines/Health & Fitness/Medicine
Apple Podcasts	#171	India/Health & Fitness
Apple Podcasts	#204	South Korea/Health & Fitness/Medicine

Talking Points

Recent interactions between the hosts and their guests.

Health Policy, Access, and Patient-Reported Outcomes

Q: How can researchers engage more investigators in PRO-focused work within NRG Oncology?

Encourage involvement by starting with disease-specific questions, leveraging existing instruments like EPIC and EQ5D and building PRO components into prospective data collection at institutions, then expanding through grant funding and collaboration with PI teams who value patient-centered outcomes.

Health Policy, Access, and Patient-Reported Outcomes

Q: Why are PROs considered as important as traditional hard endpoints like tumor control or survival in prostate cancer trials?

Because prostate cancer often has slow progression and long survival timelines, patients' quality of life, work impact, and financial burden during shorter treatment courses can be decisive in treatment choice and overall patient well-being, making PROs essential for capturing meaningful patient-centered effects.

Health Policy, Access, and Patient-Reported Outcomes

Q: What are the major considerations when incorporating patient-reported outcomes into prostate cancer trials, particularly around validation and budgeting?

Validation should rely on instruments with extensive prior use and published evidence of their reliability and validity in similar populations. Budgeting should account for the overall question burden, ideally limiting surveys to a manageable number and scheduling assessments to reduce staff workload and data loss, while integrating PROs as part of core endpoints.

NRG-HN009 Reported at the MHNCS 2026 and NRG-HN010

Q: What is the design rationale for HN010 in HER2-positive salivary gland cancers?

HN010 compares standard first-line therapy with dositaxel and trastuzumab versus an experimental regimen with TDM-1 to determine which provides similar effectiveness but potentially longer progression-free survival and better tolerability, reflecting the need to establish a first-line standard of care in this rare cancer subset.

NRG-HN009 Reported at the MHNCS 2026 and NRG-HN010

Q: What were the key early findings regarding toxicity and local control?

Early results show that six-month acute toxicity profiles were largely similar between regimens, and local-regional failure rates were also quite similar, suggesting that toxicity profiles may guide regimen selection more than differences in early cancer control.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The NRG Oncology Podcast

What is The NRG Oncology Podcast about and what kind of topics does it cover?

The content covers a wide array of topics pertinent to oncology, featuring insights from leading experts in the field. Episodes explore advancements in cancer research, clinical trials, and treatment methods while emphasizing the importance of patient outcomes and community health. Unique discussions on challenges faced by smaller institutions and veterans' cancer care also reflect the podcast's commitment to diverse perspectives in oncology. This platform is likely intended for healthcare professionals, researchers, and individuals interested in oncology developments.

Where can I find podcast stats for The NRG Oncology Podcast?

Rephonic provides a wide range of podcast stats for The NRG Oncology Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The NRG Oncology Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The NRG Oncology Podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The NRG Oncology Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The NRG Oncology Podcast?

Rephonic provides comprehensive predictive audience data for The NRG Oncology Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The NRG Oncology Podcast have?

To see how many followers or subscribers The NRG Oncology Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The NRG Oncology Podcast?

These podcasts share a similar audience with The NRG Oncology Podcast:

1. ASTRO Journals
2. White Coat Investor Podcast
3. PTI
4. JAMA Clinical Reviews
5. The Daily

How many episodes of The NRG Oncology Podcast are there?

The NRG Oncology Podcast launched 2 years ago and published 40 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The NRG Oncology Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The NRG Oncology Podcast?

Rephonic pulls ratings and reviews for The NRG Oncology Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The NRG Oncology Podcast?

Rephonic provides full transcripts for episodes of The NRG Oncology Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The NRG Oncology Podcast?

Recent guests on The NRG Oncology Podcast include:

1. Bobby Mukkamala
2. James Yu
3. Paul Harari
4. Alan Ho
5. Dr. Maria Werner-Wasik
6. Dr. Alexandra Thomas
7. Dian Wang
8. William Tseng

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days